NZM2:ETR
Novozymes A/S
€ 55.80
arrow_upward
+0.07%(+0.040) 1D
9-р сарын 30, 13:44:28 (GMT+2) · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NZM2...
Open
€ 56.16
High
€ 56.16
Low
€ 55.80
Mkt. cap
176.70Т
Avg. vol.
170.00
Volume
5.00
52-wk high
€ 61.96
52-wk low
€ 46.74
No. of employees
11 мян
Open
€ 56.16
High
€ 56.16
Low
€ 55.80
Mkt. cap
176.70Т
Avg. vol.
170.00
Volume
5.00
52-wk high
€ 61.96
52-wk low
€ 46.74
No. of employees
11 мян
News stories
From web sources and news partners
lifesciencesweden.se
·
2 цагийн өмнө
Danish biosolutions company expands U.S. factory
AD HOC NEWS
·
1 өдрийн өмнө
Novonesis stock trades at DKK 424.80 as buyback begins
www.marketscreener.com
·
2 өдрийн өмнө
Transactions under Novonesis’ share buyback program
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S
CEOEster Baiget
Employees11.1 мян
Founded2000
Headquarters-
SectorSpeciality chemicals
Websitenovonesis.com